Where can you actually buy peptides in the EU?

The short answer

The right place to buy peptides in the EU depends entirely on what you want. For the GLP-1s and other approved drugs, the only legitimate route is a prescription filled at a pharmacy — through a doctor, a telehealth weight-management service, or a clinic. Cosmetic topical peptides are sold openly by ordinary retailers. Unapproved research peptides have no legal retail channel; they exist only on a gray market where vetting and lab-testing are everything.

Evidence tier: 2 for the approved-drug routes (documented EMA authorizations and pharmacy law); the research-peptide sourcing guidance is harm-reduction, not endorsement. This is education, not medical or legal advice — and not a recommendation to buy unapproved compounds.

The key points:

• Approved drugs (GLP-1s) — prescription only, via a doctor/clinic/telehealth then a pharmacy
• Cosmetic topical peptides — sold openly by normal retailers, fully legal
• Research peptides — no legal retail route; gray market only, buy at your own risk
• Vetting is everything for anything unapproved — independent testing, not marketing

This is part of our EU cluster — start with what's available in the EU, and use our clinics directory and vendor directory.

Where do you buy approved peptides (GLP-1s) in the EU?

Evidence tier: 1–2 — EMA authorizations and pharmacy distribution.

For the peptides most people actually want — the GLP-1s — the answer is reassuringly boring: a prescription, dispensed by a pharmacy. Semaglutide (Wegovy, Ozempic, oral Rybelsus) and tirzepatide (Mounjaro) are EMA-approved (EMA: Wegovy; EMA: Mounjaro), which means they're real, quality-controlled medicines you obtain the normal way. The route to a prescription is one of three: your GP, a specialist weight-management or diabetes service, or a telehealth/clinic provider that assesses eligibility and prescribes.

This is where our clinics directory is the practical starting point — it lists telehealth and in-person providers, with coverage and pricing, so you can find one that serves your situation. The honest caveats are eligibility (weight-management prescribing is gated by BMI/comorbidity criteria), cost (often private-pay for weight loss, varying by country), and recurring shortages the EMA has been managing (EMA on GLP-1 shortages). But the place to buy is unambiguous: a prescriber, then a pharmacy. Anything offering "semaglutide, no prescription needed" is by definition not the approved drug through the approved channel. The per-drug detail is in our semaglutide and tirzepatide EU guides.

What about cosmetic topical peptides?

Evidence tier: 2 — cosmetic-market reality.

The easiest peptides to buy legally in the EU are the cosmetic topicals — copper peptides (GHK-Cu), the argireline family, and the various "peptide" serums and creams. These are regulated as cosmetics, not medicines, so they're sold openly by ordinary skincare retailers, pharmacies, and online shops across the bloc, no prescription required. If your interest is skin (anti-aging, barrier support), this is a fully legitimate, low-risk place to buy, and the products do what cosmetics do.

The one thing to keep straight is the claim boundary: a cosmetic peptide is sold for skin appearance, and the systemic or "injectable-grade" effects sometimes implied online aren't what a topical serum delivers. So buy cosmetic peptides from normal cosmetic retailers for cosmetic purposes, and don't treat a skincare product as a stand-in for a regulated drug. For where these fit in the broader picture, our EU availability overview breaks down the tiers.

Within the EU's cosmetic market there's still a quality spread worth noting: reputable skincare brands sold through pharmacies and established retailers are formulated and regulated to EU cosmetic standards, whereas a "research peptide" powder marketed for you to mix into your own serum is not a cosmetic product at all — it's the gray market wearing a skincare costume. The clean line is that a finished cosmetic from a normal retailer is the legitimate, low-risk way to use topical peptides; a vial of raw peptide sold "for research" that you're expected to reconstitute is the unapproved route regardless of how it's framed. If your interest is genuinely cosmetic, you never need to touch the gray market — the legitimate cosmetic shelf has plenty, and it comes with the consumer protection that an unregulated powder does not.

Where do people buy research peptides — and should you?

Evidence tier: 2–3 — sourcing reality and risk; not an endorsement.

This is the part people are usually really asking about, and it requires honesty. Unapproved research peptides (BPC-157, TB-500, the GH secretagogues, and the rest) have no legal retail channel in the EU — no pharmacy stocks them, no legitimate shop sells them for human use. What exists is a gray market of online "research chemical" vendors, typically selling "for research use only, not for human consumption" to sidestep medicines law. EU buyers usually face imports that draw customs scrutiny, and the legal exposure and quality uncertainty are both real, as covered in our EU availability overview.

If someone proceeds anyway, the entire game becomes vetting the vendor, because in an unregulated market quality is a property of the specific batch, not the brand. That means buying only where there's independent third-party lab testing of the actual batch (purity by HPLC/mass-spec, plus heavy-metal and endotoxin screens) — the subject of our independent lab-testing guide — and applying the checks in our how-to-verify-a-vendor guide. Our vendor directory catalogues vendors with trust signals to make that easier, and resources like Finnrick publish batch testing. None of this makes an unapproved injectable safe or clearly legal — it reduces, not removes, the risk — which is exactly why the approved routes above are the better answer whenever they apply.

What about ordering from the US or other countries?

Evidence tier: 2–3 — import/customs reality, jurisdiction-dependent.

A common workaround people consider is importing from a country where peptides seem easier to get — typically the US, with its large vendor and compounding ecosystem. The reality is that importing doesn't escape EU law; it collides with it at customs. For approved drugs, prescriptions and pharmacy distribution are national, so you generally can't bypass your own country's eligibility or pricing by ordering a prescription medicine from abroad, and importing prescription drugs without proper authorization risks seizure. For unapproved research peptides, importing is precisely where the legal and quality risk concentrates: customs screens international parcels, "research use only" labeling doesn't confer legitimacy, and a seized package is the good outcome compared with the alternatives.

There's also a quality dimension. US "compounded" GLP-1s — a frequent thing EU buyers read about — are a US-specific (and now FDA-restricted) phenomenon that doesn't have a legal EU equivalent, so chasing it usually means buying from gray-market sellers rather than legitimate compounders. And ordering research peptides internationally adds shipping time and temperature exposure on top of the verification problem, so even setting law aside, a peptide that's spent two weeks in transit through variable temperatures is a worse product. The honest synthesis is that cross-border ordering rarely solves the EU access problem — it usually trades a solvable local barrier (a prescription, a price) for an unsolvable one (customs risk plus unverifiable quality). Where an approved drug exists, the local prescription route is both safer and, in the end, more reliable.

How do you avoid scams and bad sources?

Evidence tier: 2–3 — practical buyer protection.

Wherever you buy, a few rules prevent most disasters. For approved drugs, the protection is structural: a real prescription and a registered pharmacy. Treat any site selling prescription GLP-1s without a prescription as illegitimate or counterfeit — those are the products implicated in fake-pen warnings, not the pharmacy supply. Cross-border within the EU, legitimate options work within pharmacy law (a valid prescription filled at a registered pharmacy in another member state), not around it.

For the gray market, the red flags are consistent: no independent batch testing (only a logo and a purity number), a single certificate reused across every product, "testing" done by the vendor's own lab, prices far below everyone else, pressure tactics, and crypto-only payment with no recourse. The green flags are independent batch-matched COAs, transparency, and corroboration from community testing programs. The deeper point is that for unapproved compounds you are your own regulator, so the burden of verification sits entirely with you — and if a vendor can't or won't show independent testing of the batch you're buying, that's your answer. Our safety and sourcing guide is the full playbook.

Limitations

This is educational content, not medical or legal advice, and not an endorsement of buying unapproved compounds.

• Rules, reimbursement, and enforcement vary by EU member state — this is a general overview.
• Approved drugs require a prescription — "no prescription" sellers are illegitimate or counterfeit.
• Research peptides have no legal retail route in the EU and carry legal + quality risk.
• Independent testing reduces but never removes the risk of unapproved products.
• Listing a vendor is not an endorsement — verify batch testing yourself before buying.
• Marko Maal, MSc Pharmacy reviewed this article. Reviewer attribution does not constitute a doctor-patient relationship.

The bottom line

Where to buy peptides in the EU comes down to which kind. Approved drugs like the GLP-1s: a prescription via a GP, clinic, or telehealth service, filled at a pharmacy — start with our clinics directory, and never trust a "no prescription" seller. Cosmetic topical peptides: openly and legally from normal retailers. Unapproved research peptides: no legal retail channel exists, only a gray market where independent batch testing and vendor vetting are the whole game — and where the approved routes, when they apply, are simply the safer answer.

Related on this site

• What peptides are available in the EU
• Clinics directory — telehealth & in-person prescribers
• Vendor directory
• Independent peptide lab testing & heavy metals
• How to verify a peptide vendor before you buy
• Peptide safety and sourcing: the practical guide
• Our evidence-tier framework

References

• European Medicines Agency. Wegovy (semaglutide) — EPAR / medicine overview. EMA: Wegovy — approved-drug route.
• European Medicines Agency. Mounjaro (tirzepatide) — EPAR / medicine overview. EMA: Mounjaro — approved-drug route.
• European Medicines Agency. EU actions to tackle shortages of GLP-1 receptor agonists. EMA news — supply/access context.
• Wilding JPH, Batterham RL, Calanna S, et al. 2021. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 384(11):989-1002. PMID 33567185 — efficacy basis for the approved options worth obtaining legitimately.